Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?
- PMID: 36054148
- PMCID: PMC9804888
- DOI: 10.1002/jca.22003
Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?
Abstract
Background: Patients with Human Immunodeficiency Virus (HIV) infection are at risk of thrombotic microangiopathies (TMAs) notably thrombotic thrombocytopenic purpura (TTP) and disseminated intravascular coagulation (DIC). Overlap between laboratory results exists resulting in diagnostic ambiguity.
Methods: Routine laboratory results of 71 patients with HIV-associated TTP (HIV-TTP) and 81 with DIC with concomitant HIV infection (HIV-DIC) admitted between 2015 and 2021 to academic hospitals in Johannesburg, South Africa were retrospectively reviewed. Both the PLASMIC and the International Society of Thrombosis and Haemostasis (ISTH) DIC scores were calculated.
Results: Patients with HIV-TTP had significantly (P < .001) increased schistocytes and features of hemolysis including elevated lactate dehydrogenase (LDH)/upper-limit-of-normal ratio (median of 9 (interquartile range [IQR] 5-12) vs 3 (IQR 2-5)) but unexpectedly lower fibrinogen (median 2.8 (IQR 2.2-3.4) vs 4 g/L (IQR 2.5-9.2)) and higher D-dimer (median 4.8 (IQR 2.4-8.1) vs 3.6 g/L (IQR 1.7-6.2)) levels vs the HIV-DIC cohort. Patients with HIV-DIC were more immunocompromised with frequent secondary infections, higher platelet and hemoglobin levels, more deranged coagulation parameters and less hemolysis. Overlap in scoring systems was however observed.
Conclusion: The laboratory parameter overlap between HIV-DIC and HIV-TTP might reflect a shared pathogenesis including endothelial dysfunction and inflammation and further research is required. Fibrinogen in DIC may be elevated as an acute phase reactant and D-dimers may reflect the extensive hemostatic activation in HIV-TTP. Inclusion of additional parameters in TMA scoring systems such the LDH/upper-limit-of-normal ratio, schistocytes count and wider access to ADAMTS-13 testing may enhance diagnostic accuracy and ensure appropriate utilization of plasma.
Keywords: diagnostic scoring systems; disseminated intravascular coagulation (DIC); thrombotic thrombocytopenic purpura (TTP); treatment decisions.
© 2022 The Authors. Journal of Clinical Apheresis published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest pertaining to the study.
Similar articles
-
The Combination of the Lactate Dehydrogenase/Hemoglobin Ratio with the PLASMIC Score Facilitates Differentiation of TTP from Septic DIC Without Identification of Schistocytes.Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231207629. doi: 10.1177/10760296231207629. Clin Appl Thromb Hemost. 2023. PMID: 37858603 Free PMC article.
-
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.J Thromb Haemost. 2017 Feb;15(2):312-322. doi: 10.1111/jth.13571. Epub 2017 Jan 30. J Thromb Haemost. 2017. PMID: 27868334
-
[Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].Magy Onkol. 2010 Dec;54(4):351-7. doi: 10.1556/MOnkol.54.2010.4.9. Magy Onkol. 2010. PMID: 21163766 Hungarian.
-
Thrombotic microangiopathies (TTP, HUS, HELLP).Emerg Med Clin North Am. 2014 Aug;32(3):649-71. doi: 10.1016/j.emc.2014.04.008. Epub 2014 Jun 3. Emerg Med Clin North Am. 2014. PMID: 25060255 Review.
-
Thrombotic Microangiopathies (TTP, HUS, HELLP).Hematol Oncol Clin North Am. 2017 Dec;31(6):1081-1103. doi: 10.1016/j.hoc.2017.08.010. Hematol Oncol Clin North Am. 2017. PMID: 29078925 Review.
References
-
- Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836‐2846. - PubMed
-
- Appel GB. Thrombotic microangiopathies: similar presentations, different therapies. Cleve Clin J Med. 2017;84(2):114‐130. - PubMed
-
- Rock G, Clark W, Foley R, et al. TTP: one of the TMA's‐how to sort it out. Transfus Apher Sci. 2017;56(1):57‐58. - PubMed
-
- UNAIDS . Data 2020. https://www.unaids.org/en/resources/documents/2020/unaids-data.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical